Literature DB >> 31054836

Diagnostic utility of transbronchial lung cryobiopsy: Two cases of anti-aminoacyl-tRNA synthetase syndrome with respiratory failure.

Hanako Yoshimura1, Nobuyasu Awano2, Minoru Inomata3, Naoyuki Kuse4, Mari Tone5, Tatsunori Jo6, Tamiko Takemura7, Toshio Kumasaka8, Takehiro Izumo9.   

Abstract

Transbronchial lung cryobiopsy (TBLC) is a useful and safe method for the diagnosis of interstitial lung disease (ILD). Herein, we describe the cases of two patients who developed ILD from anti-aminoacyl-tRNA synthetase syndrome with respiratory failure. TBLC was performed instead of surgical lung biopsy. There were no complications, and sufficient specimens were harvested to make the precise histopathological diagnosis. TBLC should be considered as a critical approach for the histopathological diagnosis of ILD in patients who cannot undergo surgical lung biopsy because of respiratory failure.
Copyright © 2019. Published by Elsevier B.V.

Entities:  

Keywords:  Anti-aminoacyl-tRNA synthetase antibody; Interstitial lung disease; Surgical lung biopsy; Transbronchial lung cryobiopsy

Mesh:

Substances:

Year:  2019        PMID: 31054836     DOI: 10.1016/j.resinv.2019.03.002

Source DB:  PubMed          Journal:  Respir Investig        ISSN: 2212-5345


  2 in total

1.  Feasibility, utility, and safety of transbronchial cryobiopsy for interstitial lung diseases in Japan.

Authors:  Takato Ikeda; Akira Nakao; Fumiyasu Igata; Yoshiaki Kinoshita; Hisako Kushima; Takemasa Matsumoto; Hiroshi Ishii; Kazuki Nabeshima; Masaki Fujita
Journal:  Multidiscip Respir Med       Date:  2021-01-25

2.  Combination of the Archimedes Navigation System and cryobiopsy in diagnosis of diffuse lung disease.

Authors:  Quncheng Zhang; Huili Li; Yunxia An; Dongjun Cheng; Guannan Sun; Yong Qi; Weixia Xuan; Zheng Wang; Xiaoju Zhang
Journal:  J Int Med Res       Date:  2021-07       Impact factor: 1.671

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.